Inventor · disambiguated record
Peter Mason
Also filed as: MASON PETER · MASON PETER W
38 granted patents·16 pending applications·195 citations·filing 1995–2024
97Inventor score
Files withREGENERON PHARMA13SEQIRUS UK LTD13NOVARTIS AG6GLAXOSMITHKLINE BIOLOGICALS SA5DORMITZER PHILIP3
Top patents by PatentIndex Score
54 records- 0196US11530255B2Human antibodies to Ebola virus glycoproteinREGENERON PHARMA·Filed 2020·Granted Dec 20, 2022·3 cites·18 claims
- 0296US9771414B2Human antibodies to ebola virus glycoproteinREGENERON PHARMA·Filed 2016·Granted Sep 26, 2017·18 cites·32 claims
- 0395US11078237B2Antigen delivery platformsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2018·Granted Aug 3, 2021·37 cites·19 claims
- 0494US10501526B2Human antibodies to Ebola virus glycoproteinREGENERON PHARMA·Filed 2018·Granted Dec 10, 2019·11 cites·13 claims
- 0593US10081670B2Human antibodies to Ebola virus glycoproteinREGENERON PHARMA·Filed 2017·Granted Sep 25, 2018·10 cites·13 claims
- 0692US10421804B2Anti-Zika virus antibodies and methods of useREGENERON PHARMA·Filed 2017·Granted Sep 24, 2019·11 cites·24 claims
- 0792US8252574B2Pseudoinfectious flavivirus and uses thereofMASON PETER W·Filed 2007·Granted Aug 28, 2012·13 cites·25 claims
- 0891US10829544B2Human antibodies to Ebola virus glycoproteinREGENERON PHARMA·Filed 2019·Granted Nov 10, 2020·2 cites·20 claims
- 0991US9273288B2Pseudoinfectious flavivirus and uses thereofMASON PETER W·Filed 2012·Granted Mar 1, 2016·11 cites·24 claims
- 1090US11117955B2Anti-Zika virus antibodies and methods of useREGENERON PHARMA·Filed 2019·Granted Sep 14, 2021·4 cites·18 claims
- 1190US9499588B2Flaviviruses expressing the prM, E, and NS1 proteins of other flaviviruses and uses thereofMASON PETER W·Filed 2011·Granted Nov 22, 2016·10 cites·6 claims
- 1289US8889623B2Immunostimulatory nanoparticles and related compositions, methods and systemsHOEPRICH PAUL D·Filed 2009·Granted Nov 18, 2014·9 cites·27 claims
- 1387US2025206785A1Antigen delivery platformsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2024·Application pending·0 cites
- 1483US12152067B2Human antibodies to ebola virus glycoproteinREGENERON PHARMA·Filed 2022·Granted Nov 26, 2024·0 cites·57 claims
- 1580US9708585B2Influenza virus reassortmentSEQIRUS UK LTD·Filed 2013·Granted Jul 18, 2017·4 cites·6 claims
- 1679US10865236B2Bispecific antigen-binding molecules that bind a staphylococcus target antigen and a complement component and uses thereofREGENERON PHARMA·Filed 2018·Granted Dec 15, 2020·1 cites·16 claims
- 1776US10030231B2Influenza virus reassortmentSEQIRUS UK LTD·Filed 2014·Granted Jul 24, 2018·2 cites·33 claims
- 1876US2022213149A1Antigen delivery platformsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2022·Application pending·0 cites
- 1975US10940211B2Human antibodies to S. aureus hemolysin A toxinREGENERON PHARMA·Filed 2019·Granted Mar 9, 2021·1 cites·14 claims
- 2074US11639370B2Antigen delivery platformsGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2021·Granted May 2, 2023·0 cites·19 claims
- 2174US10463748B2Human antibodies to S. aureus Hemolysin A toxinREGENERON PHARMA·Filed 2018·Granted Nov 5, 2019·1 cites·20 claims
- 2273US8945904B2Influenza virus reassortmentTRUSHEIM HEIDI·Filed 2011·Granted Feb 3, 2015·2 cites·28 claims
- 2369US11571482B2Human antibodies to S. aureus Hemolysin A toxinREGENERON PHARMA·Filed 2021·Granted Feb 7, 2023·0 cites·16 claims
- 2469US9422528B2Influenza virus reassortmentNOVARTIS AG·Filed 2013·Granted Aug 23, 2016·1 cites·29 claims
- 2569US9072702B2Reverse genetics using non-endogenous pol I promotersDORMITZER PHILIP·Filed 2010·Granted Jul 7, 2015·2 cites·20 claims
- 2668US10973899B2Flavivirus repliconsNOVARTIS AG·Filed 2016·Granted Apr 13, 2021·2 cites·13 claims
- 2768US10864264B2Influenza virus reassortmentSEQIRUS UK LTD·Filed 2019·Granted Dec 15, 2020·0 cites·42 claims
- 2867US8883729B2Nanolipoprotein particles and related compositions, methods and systemsHOEPRICH PAUL D·Filed 2009·Granted Nov 11, 2014·8 cites·35 claims
- 2966US10329537B2Influenza virus reassortmentSEQIRUS UK LTD·Filed 2014·Granted Jun 25, 2019·1 cites·7 claims
- 3066US9574181B2Influenza virus reassortment methodSEQIRUS UK LTD·Filed 2014·Granted Feb 21, 2017·0 cites·10 claims
- 3166US2020155666A1Influenza virus reassortmentSEQIRUS UK LTD·Filed 2019·Application pending·0 cites
- 3265US10610584B2Reverse genetics systemsSEQIRUS UK LTD·Filed 2017·Granted Apr 7, 2020·0 cites·21 claims
- 3363US2021147519A1Bispecific antigen-binding molecules that bind a staphylococcus target antigen and a complement component and uses thereofREGENERON PHARMA·Filed 2020·Application pending·0 cites
- 3460US11897918B2Compositions and methods to increase productionSEQIRUS UK LTD·Filed 2019·Granted Feb 13, 2024·0 cites·14 claims
- 3556US5612040ANon-infectious foot-and-mouth disease virusesUS AGRICULTURE·Filed 1995·Granted Mar 18, 1997·12 cites·5 claims
- 3655US10500266B2Influenza virus reassortmentSEQIRUS UK LTD·Filed 2017·Granted Dec 10, 2019·0 cites·23 claims
- 3755US10232031B2Influenza virus reassortmentSEQIRUS UK LTD·Filed 2014·Granted Mar 19, 2019·0 cites·12 claims
- 3855US9821052B2Reverse genetics systemsDORMITZER PHILIP·Filed 2010·Granted Nov 21, 2017·0 cites·10 claims
- 3955US2020000909A1Influenza virus reassortmentSEQIRUS UK LTD·Filed 2019·Application pending·0 cites
- 4054US2023167163A1Fusion proteins of ctl antigens for treating melanomaTHE FRANCIS CRICK INSTITUTE LTD·Filed 2022·Application pending·0 cites
- 4154US2023302109A1Antigen poolTHE FRANCIS CRICK INSTITUTE LTD·Filed 2022·Application pending·0 cites
- 4253US5824316ALeader-proteinase deleted foot-and-mouth disease viruses and their use as vaccinesUS AGRICULTURE·Filed 1996·Granted Oct 20, 1998·19 cites·5 claims
- 4353US2019284575A1Reverse genetics using non-endogenous pol i promotersSEQIRUS UK LTD·Filed 2019·Application pending·0 cites
- 4453US2014030292A1Antigen delivery platformsFRANTI MICHAEL·Filed 2011·Application pending·0 cites
- 4552US10245312B2Influenza virus reassortmentNOVARTIS AG·Filed 2016·Granted Apr 2, 2019·0 cites·21 claims
- 4652US2017342442A1Recombinant self-replicating polycistronic rna moleculesGLAXOSMITHKLINE BIOLOGICALS SA·Filed 2017·Application pending·0 cites
- 4751US2014271829A1Recombinant self-replicating polycistronic rna moleculesLILJA ANDERS·Filed 2012·Application pending·0 cites
- 4850US2020172877A1Influenza virus reassortmentSEQIRUS UK LTD·Filed 2019·Application pending·0 cites
- 4950US2014274806A1Influenza virus reassortmentSYNTHETIC GENOMICS VACCINES·Filed 2013·Application pending·0 cites
- 5046US2015166966A1Reverse genetics methods for virus rescueNOVARTIS AG·Filed 2014·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Peter Mason files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →